deoxyglucose has been researched along with Coronary Restenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aikawa, T; Al Shahi, H; Daida, H; Hiki, M; Isoda, K; Kadoguchi, T; Miyauchi, K; Miyazaki, T; Ogita, M; Okazaki, S; Ouchi, S; Sai, E; Shimada, K; Shiozawa, T; Takahashi, S; Tamura, H; Tsuboi, S; Yoshihara, T | 1 |
| Elsässer, A; Hamm, CW; Joseph, A; Kinscherf, R; Möllmann, H; Nef, HM; Rauch, M; Troidl, C; Vogt, A; Voss, S; Weber, M | 1 |
2 other study(ies) available for deoxyglucose and Coronary Restenosis
| Article | Year |
|---|---|
Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Deoxyglucose; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Percutaneous Coronary Intervention; Predictive Value of Tests; Retreatment; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Reduction of neointimal hyperplasia in porcine coronary arteries by 2-deoxy-D-glucose.
Topics: Animals; Antimetabolites; Coronary Restenosis; Deoxyglucose; Drug-Eluting Stents; Graft Occlusion, Vascular; Male; Swine; Treatment Outcome | 2009 |